NANOTHERAPEUTICS, INC.

Company Information
Address 13859 Progress Blvd.
ALACHUA, FL, 32615-9403

http://www.nanotherapeutics.com

Information

DUNS: 073438462

# of Employees: 70


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine

    Amount: $2,992,765.00

    DESCRIPTION provided by applicant Noroviruses are a group of enteropathogenic viruses belonging to the taxonomic family Caliciviridae which causes approximately of epidemic non bacterial outbreaks of ...

    SBIRPhase II2013Department of Health and Human Services
  2. GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine

    Amount: $578,711.00

    DESCRIPTION (provided by applicant): Noroviruses are a group of enteropathogenic viruses belonging to the taxonomic family Caliciviridae, which causes approximately 90% of epidemic non-bacterial outbr ...

    SBIRPhase I2011Department of Health and Human Services
  3. Development of A Synthetic Typhoid Fever Vaccine as A Substitution of Vi Vaccine

    Amount: $595,945.00

    DESCRIPTION (provided by applicant) Typhoid fever is a major cause of morbidity worldwide with an estimated incidence of 16 to 33 million infections and 500,000 to 600,000 deaths annually. It is caus ...

    SBIRPhase I2010Department of Health and Human Services
  4. ORAL BUPRENORPHINE NANOPARTICLE FORMULATION

    Amount: $116,660.00

    Not Available

    SBIRPhase II2008Department of Health and Human Services
  5. Technologies to Defeat Improvised Explosive Devices (IED’s)

    Amount: $940,875.00

    The overall goal of this Phase II project is to develop the Nanobreath® detection system for proximity detection of explosives at 50 meters, and specifically detection of peroxide improvised explosiv ...

    SBIRPhase II2006Navy Department of Defense
  6. Antimicrobial Bone Graft Substitute

    Amount: $69,938.00

    In this Phase I SBIR project, Nanotherapeutics proposes to utilize its proprietary particle delivery systems to develop an injectable bone paste formulation incorporating an anti-microbial (PHMB) as a ...

    SBIRPhase I2005Army Department of Defense
  7. ORAL BUPRENORPHINE NANOPARTICLE FORMULATION

    Amount: $775,506.00

    N/A

    SBIRPhase II2005Department of Health and Human Services
  8. Oral Therapy using Anti-Oxidants for Alzheimer's Disease

    Amount: $100,816.00

    DESCRIPTION (provided by applicant): Nanotherapeutics proposes to evaluate oral taurine therapy for Alzheimer's disease (AD). AD, the most common form of dementia among older people, affects over 4 mi ...

    SBIRPhase I2004Department of Health and Human Services
  9. ORAL BUPRENORPHINE NANOPARTICLE FORMULATION

    Amount: $98,838.00

    N/A

    SBIRPhase I2004Department of Health and Human Services
  10. Technologies to Defeat Improvised Explosive Devices (IED's)

    Amount: $99,745.00

    In this Phase I SBIR Proposal, Nanotherapeutics, Inc. proposes to demonstrate the improved proximity detection of hexamethylene triperoxidediamine (HMTD) and triacetone triperoxide (TATP) explosives u ...

    SBIRPhase I2004Navy Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government